Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Verona Pharma Plc ADR (VRNA)

Verona Pharma Plc ADR (VRNA)
63.04 x 1 63.75 x 1
Post-market by (Cboe BZX)
62.01 +1.94 (+3.23%) 04/22/25 [NASDAQ]
63.04 x 1 63.75 x 1
Post-market 62.99 +0.98 (+1.58%) 18:11 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
59.69
Day High
62.14
Open 60.30
Previous Close 60.07 60.07
Volume 1,239,300 1,239,300
Avg Vol 1,333,815 1,333,815
Stochastic %K 82.57% 82.57%
Weighted Alpha +245.90 +245.90
5-Day Change +4.20 (+7.27%) +4.20 (+7.27%)
52-Week Range 11.39 - 70.40 11.39 - 70.40
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,854,858
  • Shares Outstanding, K 80,820
  • Annual Sales, $ 42,280 K
  • Annual Income, $ -173,420 K
  • EBIT $ -155 M
  • EBITDA $ -152 M
  • 60-Month Beta 0.16
  • Price/Sales 118.43
  • Price/Cash Flow N/A
  • Price/Book 23.02

Options Overview Details

View History
  • Implied Volatility 86.54% ( -9.97%)
  • Historical Volatility 67.20%
  • IV Percentile 85%
  • IV Rank 24.42%
  • IV High 224.47% on 06/10/24
  • IV Low 41.98% on 05/10/24
  • Put/Call Vol Ratio 1.69
  • Today's Volume 1,030
  • Volume Avg (30-Day) 4,456
  • Put/Call OI Ratio 1.46
  • Today's Open Interest 52,475
  • Open Int (30-Day) 51,341

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 5
  • High Estimate -0.08
  • Low Estimate -0.40
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.20 +31.38%
on 04/07/25
Period Open: 66.81
67.31 -7.87%
on 03/24/25
-4.80 (-7.18%)
since 03/21/25
3-Month
47.20 +31.38%
on 04/07/25
Period Open: 54.67
70.40 -11.92%
on 03/03/25
+7.34 (+13.43%)
since 01/22/25
52-Week
11.39 +444.42%
on 05/30/24
Period Open: 15.72
70.40 -11.92%
on 03/03/25
+46.29 (+294.47%)
since 04/22/24

Most Recent Stories

More News
Verona Pharma Keeps Hitting New Highs

Summary Verona Pharma (VRNA) shows strong technical indicators with a 54.89% gain since 11/19, driven by Barchart's Trend Seeker buy signal. The company focuses on developing ensifentrine for respiratory...

VRNA : 62.01 (+3.23%)
Insider Sale: President and CEO of $VRNA (VRNA) Sells 162,800 Shares

DAVID ZACCARDELLI, the President and CEO of $VRNA ($VRNA), sold 162,800 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1%...

VRNA : 62.01 (+3.23%)
Insider Sale: Chief Financial Officer of $VRNA (VRNA) Sells 12,936 Shares

Mark W Hahn, the Chief Financial Officer of $VRNA ($VRNA), sold 12,936 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1%...

VRNA : 62.01 (+3.23%)
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

For Immediate ReleaseChicago, IL – October 25, 2024 – Today, Zacks Equity Research discusses Exelixis, Inc, EXEL, Blueprint Medicines BPMC, CRISPR Therapeutics CRSP, Amicus Therapeutics FOLD and Verona...

FOLD : 6.91 (+2.98%)
CRSP : 39.23 (+3.73%)
VRNA : 62.01 (+3.23%)
EXEL : 36.48 (+2.50%)
BPMC : 83.41 (-0.91%)
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major...

FOLD : 6.91 (+2.98%)
CRSP : 39.23 (+3.73%)
VRNA : 62.01 (+3.23%)
EXEL : 36.48 (+2.50%)
BPMC : 83.41 (-0.91%)
2 Standout Biotech Stocks With 32% to 63% Upside

A strong pipeline of products could potentially transform these companies, but there are risks.

RNA : 29.45 (+3.26%)
$SPX : 5,287.76 (+2.51%)
VRNA : 62.01 (+3.23%)
BMY : 49.82 (+1.80%)
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

The healthcare sector is no slouch when it comes to top-performing growth stocks.

NVDA : 98.89 (+2.04%)
VRNA : 62.01 (+3.23%)
LLY : 827.54 (+1.16%)
TMDX : 91.21 (+3.98%)
3 Stocks That Could Be Monster Winners in 2024

Don't be surprised if these three stocks take off in the new year.

CRSP : 39.23 (+3.73%)
VRNA : 62.01 (+3.23%)
MDGL : 302.72 (+2.61%)
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More

Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks.

COMP : 6.95 (+1.31%)
LCID : 2.33 (+0.43%)
$NASX : 16,300.42 (+2.71%)
VRNA : 62.01 (+3.23%)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers

Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.

SPSM : 37.72 (+2.47%)
CG : 35.69 (+2.62%)
BLTE : 58.38 (+6.75%)
AERI : 15.25 (+0.07%)
VRNA : 62.01 (+3.23%)
APLS : 17.37 (-3.66%)
CPRX : 22.60 (+2.63%)
RVNC : 3.65 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 65.32
2nd Resistance Point 63.73
1st Resistance Point 62.87
Last Price 62.01
1st Support Level 60.42
2nd Support Level 58.83
3rd Support Level 57.97

See More

52-Week High 70.40
Last Price 62.01
Fibonacci 61.8% 47.86
Fibonacci 50% 40.90
Fibonacci 38.2% 33.93
52-Week Low 11.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro